A woman in Texas was rushed to the hospital after experiencing blood clots and other symptoms. Her symptoms are similar to the six other individuals who received a COVID-19 vaccine dose from Johnson & Johnson.
Last week, health agencies in the country recommended pausing the use of the single-shot vaccine because of the rare cases of blood clots that occurred in six people. As of this writing, the shot had already been administered to around 7 million individuals in the country.
Following the new incident, the U.S. Centers for Disease Control and Prevention (CDC) advisers set to meet on Friday to discuss whether they should continue the use of the J&J vaccine. The senior U.S. health officials are also waiting for a nod.
The Texas Department of State Health Services spokesman confirmed that the CDC had notified the state agency of the recent incident.
In an emailed statement, the spokesman shared: “The patient is an adult female who was hospitalized after receiving the J&J vaccine with symptoms that appear to be consistent with the six cases reported elsewhere last week.”
They shared that they will not be providing any further information to protect the privacy of the patient. When the incident was first reported, federal authorities started to investigate the case.
Imelda Garcia, the associate commissioner for the division for infectious diseases of the Texas health agency, said in the report:
“It’s important to remember that just because something is reported it doesn’t necessarily mean that it was caused by or linked to the vaccine.”
On Tuesday, the European Medicines Agency (EMA) said they found a possible link between the rare blood clotting issue and J&J’s vaccine. But in its report, the agency said that the benefits of the shot outweigh the risks.